Article Details
Retrieved on: 2024-05-28 15:33:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Insilico Medicine's use of Generative Adversarial Networks (GANs) for drug discovery, focusing on the AI-designed TNIK inhibitor for diseases like idiopathic pulmonary fibrosis, cancer, and obesity. Alex Zhavoronkov's leadership in this area ties to the key concept and associated tags.
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here